HALOZYME THERAPEUTICS, INC.: revenue

Value{"amount": 151862000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"}
Period2018-01-01 – 2018-12-31
Statussuperseded
EntityHALOZYME THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001159036-20-000013
Retrieved: 2026-08-19T11:36:29.993166+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001159036/revenue/2018-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/62fa6949-a87d-443c-9a2c-712f9d87c2d0

History